ACT-HIB VACCINE Injection

What is ACT-HIB VACCINE

ACT-HIB Vaccine is an immunization designed to protect against infections caused by Haemophilus influenzae type b (Hib), a bacterium responsible for severe invasive diseases, especially in young children. The vaccine contains the Hib polysaccharide conjugated to a tetanus toxoid protein, which enhances the immune response, making it highly effective.

• Purpose: Prevents serious illnesses such as meningitis, pneumonia, epiglottitis, septic arthritis, and bloodstream infections caused by Hib.
• Formulation: Comes as an injection with one dose vial plus a 0.5ml syringe of diluent to reconstitute the vaccine prior to administration.
• Target Population: Primarily administered to infants and young children, as they are most vulnerable to Hib infections.
• Importance: Before widespread vaccination, Hib was a leading cause of bacterial meningitis in children under five, but incidence has dramatically dropped due to effective immunization programs.
• Vaccine Type: It is a conjugate vaccine, meaning the bacterial polysaccharide antigen is linked to a carrier protein (tetanus toxoid) to improve immune memory and effectiveness in young children.

How to use ACT-HIB VACCINE

Administering ACT-HIB Vaccine correctly ensures maximum protection and safety. It is a parenteral vaccine requiring proper handling and injection technique.

• Preparation: The vaccine vial contains a freeze-dried powder that must be reconstituted with the supplied 0.5 ml syringe of sterile diluent. Mix gently until fully dissolved; do not shake vigorously.
• Route: Given as an intramuscular injection, typically in the anterolateral thigh muscle in infants or the deltoid muscle in older children.
• Dosage Schedule: Follow local immunization guidelines, commonly given as part of routine childhood immunization at 2, 4, and 6 months of age, with a booster dose between 12-15 months.
• Administration Setting: Administered by healthcare professionals in clinics or hospitals, ensuring sterile technique and proper patient identification.
• Post-Injection Monitoring: Observe the recipient for at least 15 minutes after vaccination to detect any immediate adverse reactions, especially allergic responses.
• Documentation: Record the batch number, date of administration, and injection site in the patient’s immunization record for tracking and pharmacovigilance.
• Missed Dose: If doses are delayed, complete the series as soon as possible; do not restart the series.

Mode of Action ACT-HIB VACCINE

ACT-HIB Vaccine works by stimulating the immune system to produce protective antibodies against the Hib bacterium.

• Conjugate Vaccine: The Hib polysaccharide is chemically linked to a tetanus toxoid protein carrier, improving immunogenicity, especially in infants whose immune systems respond poorly to polysaccharide antigens alone.
• Immune Activation: After injection, antigen-presenting cells process the conjugated vaccine and present it to T-helper cells, triggering a robust and long-lasting antibody response.
• Antibody Production: The vaccine induces the formation of specific anti-Hib antibodies that neutralize the bacteria, preventing colonization and invasive disease.
• Immunological Memory: The conjugate induces memory B-cells, enabling rapid antibody production upon subsequent exposure to Hib bacteria.
• Effectiveness: The vaccine effectively reduces Hib carriage in the nasopharynx, contributing to herd immunity and lowering transmission in the community.

ACT-HIB VACCINE Interactions ACT-HIB VACCINE

Understanding drug and vaccine interactions with ACT-HIB Vaccine helps optimize immunization outcomes and patient safety.

• Other Vaccines: Can be administered concomitantly with other routine childhood vaccines such as DTaP, IPV, Hepatitis B, and pneumococcal vaccines at different injection sites without compromising efficacy.
• Immunosuppressive Therapy: Immunosuppressants or corticosteroids may reduce the immune response to the vaccine. Discuss timing of vaccination with your healthcare provider if on such medications.
• Blood Products: Recent blood transfusions or immunoglobulin administration may interfere with vaccine effectiveness; consult healthcare professionals for appropriate scheduling.
• Antipyretics and Analgesics: Paracetamol or ibuprofen may be used post-vaccination to manage fever or pain without affecting the immune response.
• Live Vaccines: ACT-HIB is an inactivated vaccine and poses no contraindications with live vaccines, but spacing recommendations per local guidelines should be followed.

Dosage of ACT-HIB VACCINE

Dosage and timing are critical to ensure optimal protection against Hib infections.

• Primary Series: Usually 3 doses of 0.5 ml each, given intramuscularly at 2, 4, and 6 months of age.
• Booster Dose: One additional 0.5 ml dose given at 12 to 15 months of age to enhance and prolong immunity.
• Older Children: Catch-up schedules are available for children who missed doses; healthcare providers will tailor accordingly.
• Adults: Generally not required, except in specific high-risk groups such as immunocompromised individuals or those undergoing splenectomy.
• Single Dose: Each vial and syringe provide a single 0.5 ml dose; discard any unused portion.

Possible side effects of ACT-HIB VACCINE

Like all vaccines, ACT-HIB can cause side effects, mostly mild and temporary, but awareness is important.

• Common Side Effects:
  • Redness, swelling, or pain at the injection site
  • Mild fever
  • Fussiness or irritability in infants
  • Loss of appetite
  • Fatigue or sleepiness
• Less Common Side Effects: Rash, vomiting, diarrhea, or mild respiratory symptoms.
• Serious Side Effects (Rare): Severe allergic reactions such as anaphylaxis; swelling of the face or throat; difficulty breathing; rapid heartbeat; dizziness.
• Management: Most side effects resolve spontaneously. Seek immediate medical care if signs of severe allergic reactions appear.
• Monitoring: Healthcare providers typically observe patients post-vaccination to manage any immediate adverse events.

ACT-HIB VACCINE Contraindications ACT-HIB VACCINE

Certain conditions require avoidance or caution when administering the ACT-HIB Vaccine.

• Severe Allergic Reaction: History of anaphylaxis or severe allergic reaction to any component of the vaccine or previous dose.
• Moderate to Severe Illness: Vaccination should be deferred in children with moderate or severe acute illness until recovery.
• Precautions: Mild illnesses like common cold are not contraindications, but the healthcare provider should assess the situation.
• Immunocompromised Patients: Though not an absolute contraindication, immune status should be considered, and vaccine benefits weighed.

Storage of ACT-HIB VACCINE

Proper storage is vital to maintain vaccine potency and ensure safety.

• Temperature: Store refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze, as freezing can damage the vaccine.
• Light Protection: Keep in original packaging to protect from light exposure.
• Handling: Handle vials carefully to avoid damage; reconstitute only immediately before use.
• Post-Reconstitution: Use the vaccine promptly after mixing; discard if not used within the recommended time (usually within a few hours).
• Transport: Maintain cold chain during transport to prevent temperature excursions.
• Expiry: Check expiry dates before administration; do not use expired vaccines.